Form A3: Subject Family History

Similar documents
Form D1: Clinician Diagnosis

UDS version 3 Summary of major changes to UDS form packets

NACC Minimum Data Set (MDS) Public Data Element Dictionary

Initial Visit Packet Forms

NACC Minimum Data Set (MDS) Data Element Dictionary

! slow, progressive, permanent loss of neurologic function.

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Dementia Past, Present and Future

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Version 3.0, March 2015

Version 3.0, March 2015

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

Sandra Weintraub, PhD Clinical Core Leader and Professor

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Recent publications using the NACC Database. Lilah Besser

Non Alzheimer Dementias

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Mild Cognitive Impairment (MCI)

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

FTD basics! Etienne de Villers-Sidani, MD!

Frontotemporal dementia:

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

Assessing and Managing the Patient with Cognitive Decline

Version 3.0, March 2015

I do not have any disclosures

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

American Medical Association, American Academy of Neurology Institute and American Psychiatric Association (2016)

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)

The Ethics of Working with Aging Donors

NACC Neuropathology (NP) Diagnosis Coding Guidebook

genetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012

Contents. Introduction. Introduction 03

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

Diagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss

Index SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Mild Cognitive Impairment

Diagnosis and Treatment of Alzhiemer s Disease

I IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136

Dementia and Healthy Ageing : is the pathology any different?

MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS

Dementia. Assessing Brain Damage. Mental Status Examination

Service Related Project. Kimberley Keegan

Confronting the Clinical Challenges of Frontotemporal Dementia

Research ALZHEIMER S DISEASE AND RISK FACTORS

The Revised National Alzheimer s Coordinating Center s Neuropathology Form Available Data and New Analyses

Behavior Problems: in Long Term Care and Assisted Living

Alzheimer's Disease Brain Failure, Stopping the Momentum. Katherine E. Galluzzi, DO, CMD, FACOFP dist.

Applications and Limitations of Cognitive Screening

Version 3.0, March 2015

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS

Dr Roger Cable NHS Dumfries and Galloway

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

Roger E. Kelley, M.D. Professor and Chairman Department of Neurology Tulane University School of Medicine New Orleans, Louisiana

Regulatory Challenges across Dementia Subtypes European View

Alzheimer's Disease, Prevalence, and Caregiving

Clinical Genetics & Dementia

Alzheimer s Disease Neuroimaging Initiative

Screening Summary (SS2)

The National Institute on Aging (NIA) of the National

Presenter Disclosure Information. I have no financial relationships to disclose:

Paper Title Theme Presentation Type Poster Presentatio n Day

Early Onset Dementia From the background to the foreground

Feil & Oppenheimer Psychological Services

Evaluations. Alzheimer s Disease A Public Health Response. Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors:

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

FTD/PPA Caregiver Education Conference March 11, 2011

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

Mild cognitive impairment A view on grey areas of a grey area diagnosis

Differentiating Dementia Diagnoses

Recognizing Dementia can be Tricky

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

NACC Uniform Data Set (UDS) DATA ELEMENT DICTIONARY for Follow-up Visit Packet (FVP)

CNADC. S. Weintraub, CNADC, Northwestern FSM, 2011 DO NOT COPY OR DISTRIBUTE WITHOUT AUTHORʼS PERMISSION

The ABCs of Dementia Diagnosis

2016 Programs & Information

Adult Neuropsychological Questionnaire

CurePSP Brain Tissue Donation Program

National Audit of Dementia Round 4 (2018) Sampling guidance for the Casenote Audit

ASHA Comments* (ASHA Recommendations Compared to DSM-5 Criteria) Austism Spectrum Disorder (ASD)

DATA CORE MEETING. Observational studies in dementia and the MELODEM initiative. V. Shane Pankratz, Ph.D.

Transcription:

Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician with experience in evaluating patients with neurological problems and psychiatric conditions. For additional clarification and examples, see UDS Coding Guidebook for Initial Visit Packet, Form A.. Are there affected first-degree relatives (biological parents, full siblings, or biological children)? Affected = having dementia or one of the non-normal diagnoses listed in Appendix on page 5 No Yes a. In this family, is there evidence for an AD mutation? If Yes, select predominant mutation. NOTE: APOE should not be reported here. No (SKIP TO QUESTION a) Yes, APP Yes, PS- (PSEN-) Yes, PS- (PSEN-) Yes, whether mutation exists (SKIP TO QUESTION a) b. Source of evidence for AD mutation (check one): a. In this family, is there evidence for an FTLD mutation? If Yes, select predominant mutation. 4 No (SKIP TO QUESTION 4a) Yes, MAPT Yes, PGRN Yes, Corf7 Yes, FUS Yes, whether mutation exists (SKIP TO QUESTION 4a) b. Source of evidence for FTLD mutation (check one): National Alzheimer s Coordinating Center (6) 54-67 fax: (6) 66-57 naccmail@uw.edu www.alz.washington.edu UDS Version., March 5 Page of 5

4a. In this family, is there evidence for a mutation other than an AD or FTLD mutation? (If No or, SKIP TO QUESTION 5a) No (SKIP TO QUESTION 5a) Yes (SPECIFY): (SKIP TO QUESTION 5a) 4b. Source of evidence for other mutation (check one): BIOLOGICAL Parents Provide information on biological parents below. If birth year is unknown, please provide an approximate year on the Initial Visit Form A and ensure that it is consistently reported on any Follow-up Visit Form A, as applicable. If it is impossible for the subject and co-participant to estimate the birth year, enter =. For any biological parent with a neurological or psychiatric condition, the entire row must be filled out. If the clinician cannot determine the primary neurological condition after reviewing all available evidence, enter = in the condition column, and then skip the subsequent questions in the row. For a biological parent with no neurological or psychiatric problem, enter =N/A no neurological problem or psychiatric condition in the condition column, and then skip the subsequent questions in the row. (/=) (=N/A, = unknown) Primary Dx** See CODES, below ( = unknown) 5a. Mother / 5b. Father / *Codes for neurological problems and psychiatric conditions Cognitive impairment/behavior change Parkinsonism ALS 4 Other neurologic condition such as multiple sclerosis or stroke 5 Psychiatric condition such as schizophrenia, bipolar disorder, alcoholism, or depression N/A no neurological problem or psychiatric condition **Codes for primary diagnosis See Appendix on page 5 of this form. ***Codes for method of evaluation Autopsy Examination Medical record review from formal dementia evaluation 4 Review of general medical records AND co-participant and/or subject telephone 5 Review of general medical records only 6 Subject and/or co-participant telephone 7 Family report National Alzheimer s Coordinating Center (6) 54-67 fax: (6) 66-57 naccmail@uw.edu www.alz.washington.edu UDS (v., March 5) Initial Visit Form A: Subject Family History Page of 5

Year of birth for full siblings and biological children: If birth year is unknown, please provide an approximate year on UDS Initial Visit Form A and UDS Follow-up Visit Form A so that the sibling or child with unknown birth year ends up in correct birth order relative to the other siblings/children. Example: A subject is the oldest of three children. The subject was born in 4 and the middle sibling in 4; the youngest sibling s birth year is unknown. An approximate birth year of 44 or later should be assigned to the youngest sibling. Use that same birth year on FTLD Module Form Aa, if applicable, and across all UDS visits so that any new information on a particular sibling or child can be linked to previously submitted information. If it is impossible for the subject and coparticipant to estimate the birth year, enter =. Full siblings 6. How many full siblings does the subject have? If subject has no full siblings, SKIP TO QUESTION 7; otherwise, provide information on all full siblings below. For any full sibling with a neurological or psychiatric condition, the entire row must be filled out. If the clinician cannot determine the primary neurological condition after reviewing all available evidence, enter = in the condition column, and then skip the subsequent questions in the row. For a sibling with no neurological or psychiatric problem, enter =N/A no neurological problem or psychiatric condition in the condition column, and then skip the subsequent questions in the row. See next page of form for list of codes (/=) ( = N/A, =unknown) Primary Dx** See CODES on page 4 ( = unknown) 6a. Sibling / 6b. Sibling / 6c. Sibling / 6d. Sibling 4 / 6e. Sibling 5 / 6f. Sibling 6 / 6g. Sibling 7 / 6h. Sibling / 6i. Sibling / 6j. Sibling / 6k. Sibling / 6l. Sibling / 6m. Sibling / 6n. Sibling 4 / 6o. Sibling 5 / 6p. Sibling 6 / 6q. Sibling 7 / 6r. Sibling / 6s. Sibling / 6t. Sibling / National Alzheimer s Coordinating Center (6) 54-67 fax: (6) 66-57 naccmail@uw.edu www.alz.washington.edu UDS (v., March 5) Initial Visit Form A: Subject Family History Page of 5

biological children 7. How many biological children does the subject have? If subject has no biological children, END FORM HERE; otherwise, provide information on all biological children below. For any biological child with a neurological or psychiatric condition, the entire row must be filled out. If the clinician cannot determine the primary neurological condition after reviewing all available evidence, enter = in the condition column, and then skip the subsequent questions in the row. For a biological child with no neurological or psychiatric problem, enter =N/A no neurological problem or psychiatric condition in the condition column, and then skip the subsequent questions in the row. (/=) ( = N/A, =unknown) Primary Dx** See CODES, below ( = unknown) 7a. Child / 7b. Child / 7c. Child / 7d. Child 4 / 7e. Child 5 / 7f. Child 6 / 7g. Child 7 / 7h. Child / 7i. Child / 7j. Child / 7k. Child / 7l. Child / 7m. Child / 7n. Child 4 / 7o. Child 5 / *Codes for neurological problems and psychiatric conditions Cognitive impairment/behavior change Parkinsonism ALS 4 Other neurologic condition such as multiple sclerosis or stroke 5 Psychiatric condition such as schizophrenia, bipolar disorder, alcoholism, or depression N/A no neurological problem or psychiatric condition **Codes for primary diagnosis See Appendix on page 5 of this form. ***Codes for method of evaluation Autopsy Examination Medical record review from formal dementia evaluation 4 Review of general medical records AND co-participant and/or subject telephone 5 Review of general medical records only 6 Subject and/or co-participant telephone 7 Family report National Alzheimer s Coordinating Center (6) 54-67 fax: (6) 66-57 naccmail@uw.edu www.alz.washington.edu UDS (v., March 5) Initial Visit Form A: Subject Family History Page 4 of 5

**APPENDIX : PRIMARY DIAGNOSIS CODES 4 Mild cognitive impairment (MCI), not otherwise specified 4 MCI amnestic, single domain 4 MCI multiple domain with amnesia 4 MCI single domain nonamnestic 44 MCI multiple domain nonamnestic 45 Impaired, but not MCI 5 Alzheimer s disease dementia 7 Dementia with Lewy bodies Vascular cognitive impairment or dementia Impairment due to alcohol abuse Dementia of undetermined etiology Behavioral variant frontotemporal dementia Primary progressive aphasia, semantic variant Primary progressive aphasia, nonfluent/agrammatic variant Primary progressive aphasia, logopenic variant Primary progressive aphasia, not otherwise specified 4 Clinical progressive supranuclear palsy 5 Clinical corticobasal syndrome/corticobasal degeneration 6 Huntington s disease 7 Clinical prion disease Cognitive dysfunction from medications Cognitive dysfunction from medical illness Depression Other major psychiatric illness Down syndrome Parkinson s disease 4 Stroke 5 Hydrocephalus 6 Traumatic brain injury 7 CNS neoplasm Other Amyotrophic lateral sclerosis Multiple sclerosis Specific diagnosis unknown (acceptable if method of evaluation is not by autopsy, examination, or dementia evaluation) Neuropathology diagnosis from autopsy 4 Alzheimer s disease neuropathology 4 Lewy body disease neuropathology 4 Gross infarct(s) neuropathology 4 Hemorrhage(s) neuropathology 4 Other cerebrovascular disease neuropathology 4 ALS/MND 4 FTLD with Tau pathology Pick s disease 4 FTLD with Tau pathology CBD 4 FTLD with Tau pathology PSP 44 FTLD with Tau pathology argyrophyllic grains 45 FTLD with Tau pathology other 46 FTLD with TDP-4 4 FTLD other (FTLD-FUS, FTLD-UPS, FTLD NOS) 44 Hippocampal sclerosis 45 Prion disease neuropathology 4 Other neuropathologic diagnosis not listed above ***APPENDIX : METHOD OF EVALUATION. Autopsy If the autopsy was performed at an outside institution, you must have the report to code as diagnosis by autopsy.. Examination The subject must have been examined in person at your ADC/ institution or by genetic studies staff associated with your ADC/ institution to code as diagnosis by examination. Medical records may or may not have been used when assigning diagnosis.. Medical record review from formal dementia evaluation Medical records should be from an examination that focused specifically on dementia; that was performed by a neurologist, geriatrician, or psychiatrist; and that includes a neurologic examination, an imaging study, and cognitive testing (e.g., MMSE, Blessed, or more formal tests). A telephone may also be used to collect additional information. 4. Review of general medical records AND co-participant and/or subject telephone General medical records can be of various types, including those from a primary-care physician s office, hospitalization records, nursing home records, etc. They may include a neurologic exam and a cognitive test such as the MMSE along with a medical history. The telephone with the subject and/or the coparticipant should include a medical history to capture the nature and presentation of cognitive deficits, if present, and age of onset if symptomatic. If the subject is normal or is in the early stages of cognitive impairment, brief formal cognitive testing should be included in the. 5. Review of general medical records ONLY See definition No. 4 above. If general medical records are used to diagnose a subject as demented or not demented, they should include a medical history, neurologic exam, and a cognitive test such as an MMSE. In most cases, general medical records alone should not be used to assign a diagnosis of mild cognitive impairment, or of any of the FTLD spectrum subtypes, or of parkinsonian disorders other than Parkinson s disease. 6. Subject and/or co-participant telephone See definition No. 4 above. 7. Family report Family report should be coded when the co-participant for the family reports a subject as having been diagnosed with a particular disorder. In most cases, family report alone should not be used to assign a diagnosis of mild cognitive impairment, or of any of the FTLD spectrum subtypes, or of parkinsonian disorders other than Parkinson s disease. National Alzheimer s Coordinating Center (6) 54-67 fax: (6) 66-57 naccmail@uw.edu www.alz.washington.edu UDS (v., March 5) Initial Visit Form A: Subject Family History Page 5 of 5